Skip to main content

Day: November 8, 2022

HCI Group Reports Third Quarter 2022 Results

Claims from Hurricane Ian Remain Consistent with Prior DisclosureGross Premiums Earned Grew 21% Over Last YearThird Quarter Loss Ratio Declined to 41.4% Excluding Ian TAMPA, Fla., Nov. 08, 2022 (GLOBE NEWSWIRE) — HCI Group, Inc. (NYSE:HCI), a holding company with operations in homeowners insurance, information technology services, real estate, and reinsurance, reported a net loss of $51.5 million, or $5.66 loss per share, in the third quarter of 2022 compared with net loss of $4.9 million, or $0.72 loss per share, in the third quarter of 2021. Adjusted net loss (a non-GAAP measure which excludes net unrealized gains or losses on equity securities) was $51.2 million, or $5.62 loss per share, in the third quarter of 2022 compared with adjusted net loss of $3.5 million, or $0.64 loss per share, in the third quarter of 2021. This press...

Continue reading

Aterian Reports Third Quarter 2022 Results

Reports Third Quarter 2022 Net Revenue of $66.3 Million Targeting Adjusted EBITDA Profitability in the Second Half of 2023 Driven Primarily by Improving International Shipping Rates and Cost Reductions NEW YORK, Nov. 08, 2022 (GLOBE NEWSWIRE) — Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”) today announced results for the third quarter ended September 30, 2022.  Third Quarter 2022 HighlightsThird quarter 2022 net revenue declined 2.6% to $66.3 million, compared to $68.1 million in the third quarter of 2021. Third quarter 2022 gross margin declined to 45.5%, compared to 50.2% in the third quarter of 2021, primarily due to the liquidation of high priced excess inventory. Third quarter 2022 contribution margin declined to 1.1% from 12.1% in the third quarter of 2021, primarily due to the liquidation of high priced excess...

Continue reading

Gulf Island Reports Third Quarter 2022 Results

THE WOODLANDS, Texas, Nov. 08, 2022 (GLOBE NEWSWIRE) — Gulf Island Fabrication, Inc. (NASDAQ: GIFI) (“Gulf Island” or the “Company”), a leading steel fabricator and service provider to the industrial and energy sectors, today announced results for the third quarter 2022. THIRD QUARTER 2022 SUMMARY (as compared to the third quarter 2021)Revenue of $39.6 million, 102.1% increase y/y Consolidated income from continuing operations and EBITDA of $0.6 million and $1.9 million, respectively, including loss from Shipyard Division of $1.4 million, non-cash impairment charge of $0.5 million and gain from insurance recoveries of $1.3 million Operating income and EBITDA for Services Division of $2.4 million and $2.8 million, respectively Operating income and EBITDA for Fabrication Division of $2.1 million and $2.9 million, respectively,...

Continue reading

CytomX Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update

– Advancing wholly owned, next-generation conditionally activated therapeuticsCX-2051 (EpCAM-directed ADC) and CX-801 (Interferon alpha-2b), with INDs anticipated in 2023 – – CX-904, Company’s first clinical stage Probody T-cell bispecific (EFGRxCD3), continues to advance in Phase 1 dose escalation – – Continued progress with Phase 2 collaborator programs CX-2029 (AbbVie, Phase 2) and BMS-986249 (Bristol Myers Squibb, Phase 2) – SOUTH SAN FRANCISCO, Calif., Nov. 08, 2022 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of conditionally activated oncology therapeutics, today reported third quarter 2022 financial results and provided a business update. “CytomX’s progress in the third quarter highlights the potential of our pipeline as well as the breadth and versatility...

Continue reading

ARS Pharmaceuticals Closes Merger with Silverback Therapeutics

Over $280 Million in Combined Cash and Securities and at least Three Years Operating Runway to Support Launch and Commercialization of neffy® in the U.S., if Approved neffy® NDA Currently Under FDA Review; PDUFA Anticipated Mid-2023 MAA validated in the European Union Under Review SAN DIEGO, Nov. 08, 2022 (GLOBE NEWSWIRE) — ARS Pharmaceuticals, Inc. (Nasdaq: SPRY) (ARS or the Company), a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from severe allergic reactions that could lead to anaphylaxis, today announced the closing of its merger with Silverback Therapeutics, Inc. (Silverback). This follows the satisfaction of all customary closing conditions, including approval of the merger by the stockholders of Silverback. The combined company will operate as ARS Pharmaceuticals,...

Continue reading

Yara prices debut US dollar green notes offering

Oslo, 8 November 2022: Yara International ASA today priced its debut offering of USD 600 million 7.378% Green Notes due 2032 (the “Notes”). The Notes will be issued pursuant to Rule 144A/Regulation S. Yara intends to allocate an amount equivalent to the net proceeds from this offering to finance, or refinance in whole or in part, one or more, new or existing, green investments or assets in accordance with Yara’s green financing framework. Yara’s green financing framework and a second party opinion thereon issued by CICERO Shades of Green are available at Yara’s webpage at the following link: https://www.yara.com/investor-relations/reports-presentations/. The expected ratings of the notes from Moody’s and Standard & Poor’s are Baa2 and BBB, respectively. Contact Nina Kleiv, Head of Finance, Treasury & InsuranceMobile:...

Continue reading

HII Makes Positive Impact with Third Annual Global Day of Caring Initiative

HII Mission Technologies Day of Caring 2022 Volunteers helped build a retaining wall to give hikers a safer path when entering/exiting a newly built foot bridge in Front Royal, Virginia.MCLEAN, Va., Nov. 08, 2022 (GLOBE NEWSWIRE) — HII’s (NYSE: HII) Mission Technologies division hosted its annual Global Day of Caring on Saturday, Nov. 5. More than 300 employees and their family members completed community service projects in Arizona, Florida, Georgia, Hawaii, Massachusetts, Nevada, Ohio, Pennsylvania, South Carolina, Texas, Virginia, Washington and South Korea. “Supporting communities where we live and work is at the core of who we are,” said Andy Green, president of HII’s Mission Technologies division. “The mission-critical solutions we deliver everyday connect us through service to our nation, and the Global Day of Caring...

Continue reading

Baxter Highlights New Home Dialysis and HDx Therapy Data in 14 Clinical Presentations at Kidney Week 2022

Controlled study at 21 hospitals shows remote patient management reduces adverse events for home peritoneal dialysis patients New ex vivo study demonstrates superior performance of the Theranova dialyzer in effectively balancing higher removal of large middle-molecule toxins and albumin stability during hemodialysisDEERFIELD, Ill., Nov. 08, 2022 (GLOBE NEWSWIRE) — Baxter International Inc. (NYSE:BAX), a global innovator in kidney care, advanced scientific exchange with 14 new data presentations about the role innovation plays in increasing access to and quality of home dialysis and expanded hemodialysis (HDx) care at Kidney Week 2022, Nov. 3-6, Orlando, Florida. Key data highlighted include:A study indicating a significant reduction in all-cause mortality and fluid balance, and cardiovascular and metabolic related adverse...

Continue reading

Atlantic American Corporation Reports Third Quarter Results for 2022

ATLANTA, Nov. 08, 2022 (GLOBE NEWSWIRE) — Atlantic American Corporation (Nasdaq- AAME) today reported net loss for the three month period ended September 30, 2022 of $0.7 million, or $0.04 per diluted share, as compared to net loss of $0.9 million, or $0.05 per diluted share, for the comparable period in 2021. For the nine month period ended September 30, 2022, the Company reported net income of $0.5 million, or $0.01 per diluted share, as compared to net income of $1.6 million, or $0.06 per diluted share, for the comparable period in 2021.   The decrease in net loss for the three month period ended September 30, 2022 was primarily attributable to more favorable loss experience in the life and health operations, partially offset by a decrease in unrealized gains of $3.5 million, from the comparable period in 2021. The decrease...

Continue reading

Jaime Sayre Kawaja Promoted to General Manager of WFLX in West Palm Beach

ATLANTA, Nov. 08, 2022 (GLOBE NEWSWIRE) — November 8, 2022… Gray Television, Inc. (“Gray”) (NYSE: GTN) has promoted Jaime Sayre Kawaja to the role of General Manager / General Sales Manager of WFLX Fox 29 in West Palm Beach, Florida (DMA 39).Jaime brings 25 years of experience in sales and marketing to her new position. She began her career as an intern at Gray’s WKYT (CBS) in Lexington, Kentucky. The following year, she joined the station full-time as an account executive. Over the years Jaime held numerous positions at WKYT including regional, digital and local sales manager.  Jaime has served as the station’s General Sales Manager since 2018.  Jaime holds a Bachelor of Science in Marketing/Management from the University of Kentucky.  She is active in several advertising, media and service organizations, including Women Leading...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.